The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study

Launched by UNIVERSITY COLLEGE, LONDON · Dec 23, 2016

Keywords

ClinConnect Summary

The PEACE Study is a clinical trial focused on understanding advanced cancer by collecting tissue samples from patients after they have passed away. This research aims to gather valuable information from various tumor sites to help scientists study cancer more effectively. By doing this, the study hopes to improve our understanding of how different treatments work and how cancer develops, which could lead to better therapies in the future.

To be eligible for this study, participants must be 18 years or older and have a confirmed diagnosis of any solid tumor cancer that has spread to other parts of the body, except for certain brain tumors. Participants (or their loved ones) need to give consent for tissue donation after death. This study is currently recruiting, and it's open to all genders. Those interested can expect that their donated tissue will be used for important cancer research, contributing to advancements in treatment and care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 years or older
• • Confirmed diagnosis of any form of solid malignancy with metastatic disease (where the site of origin is known or unknown), with the exception of primary brain tumour in which there may not be evidence of metastatic disease
• • Oral and written informed consent from patient to enter the study and to undergo tumour harvesting after death or informed consent from a person in a qualifying relationship after the patient has died.
• Exclusion Criteria:
• • Medical or psychiatric condition that would preclude informed consent
• • History of intravenous drug abuse within the last 5 years
• • History of known high-risk infections (e.g. HIV/AIDS-positive, hepatitis B/C, tuberculosis and Creutzfeldt-Jacob disease).